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background: This study was designed to develop an animal model to test the response of endometrium to local progestin delivery.
methods: Proliferative human endometrium was subcutaneously grafted in two groups of SCID mice that received, 2 days before, a
subcutaneous estradiol (E2) pellet and, for half of them, an additional implant of levonorgestrel (LNG). Mice were sacriﬁced 1, 2, 3 or 4
weeks after endometrial implantation and grafts were histologically analysed. Proliferation, steroid hormone receptors, blood vessels and
stromal decidualization in both groups (E2 and LNG) were immunohistologically evaluated and compared with proliferative endometrium
and endometrium from women with an LNG intrauterine device.
results: Grafts presented normal morphological endometrial characteristics. The expression of progesterone receptors was signiﬁcantly
decreased in glands and stroma of the LNG group as compared with the E2 group at all times. A signiﬁcant decrease was also observed in the
stromal expression of estrogen receptor-a in the LNG group. At 4 weeks, the mean cross-sectional area of vessels was signiﬁcantly higher
after LNG treatment.
conclusions: These morphological and immunohistochemical characteristics are similar to those observed in women treated with
local LNG. This mouse model might facilitate further investigations needed to understand the mechanisms responsible for the breakthrough
bleeding frequently observed in progestin users.
Key words: levonorgestrel / endometrium / mouse model / endometrial transplants
Introduction
The levonorgestrel-releasing intrauterine system (LNG-IUS) is
considered as an efﬁcient contraceptive. However, it is commonly
associated with vaginal bleeding and spotting (breakthrough bleeding,
BTB) in the ﬁrst few months of use. Irregular bleeding is the most
common reason for discontinuation of progestin-only contraception
(Findlay, 1996; Hickey et al., 1999). LNG delivered locally by the
LNG-IUS is known to alter the morphology and function of
endometrium (Critchley et al., 1998a). Morphological changes
include pseudodecidualization in the stromal compartment associated
with leukocytes inﬁltration, atrophy of glandular and surface epi-
thelium, and alterations in the vasculature (Jones and Critchley,
2000). These latter morphological modiﬁcations include dilatation
and changes in shape, basement membrane components and pericyte
support (Hickey et al., 2000; Hickey and Fraser, 2003). Furthermore,
an increase in blood vessel number, size and density associated with a
decrease in the pericyte coating have been shown after short-term
exposure to LNG-IUS (Stephanie et al., 2007)) and hypothesized to
contribute to vascular fragility and BTB (Hickey et al., 2000; Rogers
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regulation of oestrogen and progesterone receptors as well as cell
proliferation (Critchley et al., 1998b; Salmi et al., 1998). This alteration
in sex steroid receptor expression may affect endometrial cytokine
release (Jones and Critchley, 2000). The paracrine mechanisms
implicated in bleeding after intrauterine LNG delivery remain to be
elucidated.
Endometrium obtained from women using LNG-IUS provides an
opportunity to study the effect of a high dose of local progestin
delivery upon endometrial development. Nevertheless, because of
obvious practical and ethical limitations in humans, the animal
models provide an invaluable tool to study in vivo early events
through the examination of morphology of transplanted tissue. In
the future, events associated with the pathogenic process underlying
BTB should be identiﬁed and the possible efﬁcacy of various thera-
peutic modalities should be assessed. Uterine bleeding does not
occur in animals except in monkeys. The high costs of monkey
handling limit the use of this animal model for research. As
rodents do not have uterine bleeding, transplantation of endometrial
tissue is needed. For this purpose, severe combined immunodeﬁ-
cient mice (SCID) were used as they are characterized by a
combined congenital deﬁciency in T and B lymphocyte function
and therefore successfully host various heterotransplants (Phillips
et al., 1989). Previous studies have described the success of
human tissue grafts which retain their morphological and biochemical
characteristics after transplantation in different mice strains
(Shimosato et al., 1976; Kim et al., 1978; Satyaswaroop et al.,
1983; Awwad et al., 1999).
The aim of this study was to validate the suitability of SCID mice
grafted with human endometrium as an experimental model to
mimic the effects of LNG in women. The morphology of both
groups of endometrial implants was compared with that of prolifera-
tive eutopic endometrium and eutopic endometrium treated with
local delivery of LNG. Speciﬁc features of these implants such as cell
proliferation, steroid hormone receptors and the vasculature were
also characterized.
Materials and Methods
Collection of human endometrium
The use of human tissue for this study was approved by the Ethical Com-
mittee of the University of Liege. Proliferative endometrium (5–9 cycle
days) was obtained from 6 reproductive aged women (aged 31–38
years) without endometriosis undergoing surgery for benign purposes
(myoma, infertility). They had regular menstrual cycles and did not
receive any hormonal treatment for at least 3 months before surgery.
The endometrial biopsy was taken with a Cornier Pipelle suction
curette (C.C.D. International, Paris, France), placed in sterile phosphate-
buffered saline (PBS) solution, pH 7.3, and immediately transported to
the laboratory. Endometrial biopsies were cut into pieces of 1–2 mm
3;
some fragments were ﬁxed in 4% buffered formaldehyde, dehydrated
and embedded in parafﬁn. Sections were stained with haematoxylin-eosin
for histological conﬁrmation of the menstrual phase (Noyes et al., 1950).
Eight endometrial biopsies were also obtained from women (mean age
39 years) exposed to LNG-IUS (20 mg/day, Mirenaw, Bayer Schering
Pharma, Berlin, Germany) for a period of 1 month to compare their
morphology with the grafts of the LNG group at 4 weeks.
Animals
FemaleSCID/SCIDCB17mice(n ¼ 64)of8–10weekswereobtainedfrom
Charles River Laboratories (Brussels, Belgium) and housed under a barrier
husbandry in a well-controlled, pathogen-free environment with a 12 h
light/12 h dark cycle. All housing materials, food and water were autoclaved
before use. Mice were fed ad libitum on laboratory chow and water. Exper-
iments were approved by the Liege University Animal Ethics Committee.
Transplantation into SCID mice and tissue
processing
All surgical procedures were conducted under parenteral anaesthesia with
an injection of a solution containing 10 mg/kg of Xylalinw (Ceva Sante
Animale, Libourne, France) and 80 mg/kg body weight of Ketamine
1000 Cevaw (Ceva Sante Animale) in a sterile laminar ﬂow hood.
One group of 32 mice was implanted subcutaneously in the neck with a
pellet of 17b-estradiol (E2; 1.72 mg/60 day release; Innovative Research of
America) (¼ E2 group). A second group of 32 mice was implanted simul-
taneously with a pellet of 17b-estradiol and an implant of LNG (20 mg/
day) (LNG group). After 2 days, 10 fragments of fresh human proliferative
endometrium (1–2 mm
3) were grafted subcutaneously in the dorsal
region of each animal next to the implant of LNG. Depending on the
size of the endometrial biopsy, we grafted simultaneously at least four
mice of the same hormonal treatment group, one at each time point.
Eight mice per group were sacriﬁced at 1, 2, 3 or 4 weeks after endome-
trium transplantation. To evaluate the endometrial lesions, the dorsal
skin was largely opened in order to perform a resection of grafts adherent
to the skin. All specimens were ﬁxed in 4% buffered formalin, and
embedded in parafﬁn. Sections were stained with haematoxylin–eosin
and with haematoxylin–safran for histological analysis, or used for
immunohistochemistry.
Immunohistochemistry
Cell proliferation was evaluated using a monoclonal mouse anti-Ki-67
antibody (MIB-1, M7240, DAKO, Glostrup, Denmark, dilution 1:100)
and human steroid hormone receptors were evaluated using monoclonal
mouse anti-human oestrogen receptor alpha (ERa, NCL-ER-6F11,
Novocastra Laboratories Ltd, UK, dilution1:50), progesterone A-form
receptor (PRA, NCL-L-PRG-312, Novocastra Laboratories Ltd, dilution
1:100) and progesterone B-form receptor (PRB, NCL-PRG-B, Novocastra
Laboratories Ltd, dilution 1:100).
Stromal decidualization was conﬁrmed by a monoclonal mouse anti-
human insulin-like growth factor binding protein-1 (IGFBP-1, 100056,
Medix Biochemica, Kauniainen, Finland, dilution 1:100).
Vascular smooth muscle cells were stained using a monoclonal mouse
antibody against a- Smooth Muscle Actin (a-SMA, F3777, Sigma-Aldrich
Chemie Gmbh, Munich, Germany, dilution 1:1000) and blood vessels
were stained using an antibody against human and mouse collagen IV
(SIF 100, guinea pig polyclonal antibody produced in our laboratory,
dilution 1:750).
To unmask antigens on parafﬁn sections (5 mm thick), slides were incu-
bated 40 min in 0.025% Trypsine (S 2012, DAKO) for a-SMA and SIF 100,
or autoclaved for 11 min at 1268C and 1.4 bar in citrate buffer for the
others antibodies. Endogenous peroxidase was subsequently blocked by
3% H2O2/H2O for 20 min and non-speciﬁc binding was prevented by
incubation in PBS/bovine serum albumin 10% (Fraction V, Acros Organics,
NJ, USA) for 30 min (for Ki-67, a-SMA and SIF 100) or in normal goat
serum (for PRA,P R B,E R a and IGFBP-1). Sections were incubated for
90 min at room temperature with the primary antibody. Slides were
then incubated 30 min at room temperature with an appropriate second-
ary antibody: rabbit anti guinea pig Ig-HRP (P0141, DAKO; dilution 1:50)
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lowed by incubation with a streptavidin/HRP complex (P0397, DAKO,
dilution 1:500) at room temperature for 30 min. Staining was done with
3-30-diaminobenzidine hydrochloride (K3468, DAKO) for 3 min. Slides
were ﬁnally counterstained with haematoxylin and mounted with Eukitt
medium for microscope observation. Negative controls were performed
both by omission of the primary antibody and by replacement of this
primary antibody by an appropriate isotype control (mouse IgG1, X
0931, DAKO).
Scoring and analysis of immunoreactivity
The immunostaining intensity of receptors (PRA,P R B,E R a) and the distri-
bution of speciﬁc staining were assessed in a semi-quantitative manner by
an HS-score (Huang et al., 1996; Vereide et al., 2006). The HS-score has
been evaluated as follows: HS ¼
P
(Pi   i)/100, where Pi denotes the
percentage of stained cells and i denotes the intensity of the staining
ranging from 0 to 3. A score of 0 indicated an absence of staining and a
score of 1, 2 and 3 indicated weak, moderate and intense immunostaining,
respectively. The HS-score evaluation was performed blinded by a trained
biologist. Glandular and stromal endometrial cells were analysed separ-
ately. At least ﬁve representative ﬁelds ( 40 objective on an Olympus
Vanox AHBT3 microscope, Aartselaar, Belgium) within each section
were selected for assessment.
The cell proliferation of glandular and stromal endometrial cells was
evaluated on the complete ﬁeld by giving a score according to the percen-
tage of positive stained cells: 0 ¼ no immunostaining, 1 ¼ ,25% immu-
nostaining, 2 ¼ from 25 to 75% immunostaining and 3 ¼ .75%
immunostaining.
Analysis of endometrial vasculature
For each graft, two successive sections were stained either for SIF 100 or
for a-SMA to analyse the vascular morphological changes induced at 4
weeks by LNG compared with E2. All blood vessels were delineated
manually at  400 magniﬁcation using Photoshop software (version
7.0.1) throughout the totality of each section. Images were therefore
binarized and analysed using the NIH ImageJ analysis free software
(http://rsb.info.nih.gov/ij/) to determine the number of blood vessels
per stromal surface unit as well as their mean area. All these parameters
were calculated for each image individually. Then, the mean value of these
parameters was determined for each mouse. Finally, the mean+SEM
vessel number per unit of tissue area and the relative vascular area for
all patients of the same group were determined.
Statistics
Values were presented as mean+SEM. Scoring results were analysed
using GraphPad Prism (version 5.00) by an ANOVA test followed by
the Bonferroni’s multiple comparison post hoc test on E2 groups in function
of time and compared with proliferative eutopic endometrium (Prolif.). A
two-way ANOVA test followed by a Bonferroni post hoc test was used to
compare the two different treatment mice groups (E2 and LNG) in func-
tion of time. Finally, a t-test was used to compare the proliferative eutopic
endometrium (Prolif.) or the LNG group at 4 weeks to LNG-IUS samples.
The vessel number per unit of stromal tissue area and the mean vascular
area were compared by a Mann–Whitney U-test. Differences were
considered signiﬁcant when P   0.05.
Results
From a total of 64 SCID mice, 52 survived the procedure (27 in
the E2 group and 25 in the LNG group) and 12 died after
anaesthesia. Endometrial transplants were recovered from all
surviving mice.
Histological morphology
All endometrial biopsies used for graft displayed normal proliferative
features as described by Noyes et al. (1950). The morphology of
human endometrial transplants was well preserved. Necrosis was
only observed in transplants removed after 1 week from E2 group.
Transplants consisted of an endometrium-like tissue with typical
glands and stroma surrounded by a thin capsule of connective tissue
(Fig. 1). In the E2 group, we observed after 1 week, small and
round glands with pseudostratiﬁcation of the nuclei surrounded by a
dense stroma. At 2 weeks, the glands became dilated with a persist-
ence of the pseudostratiﬁed structure of the glandular epithelium
and a less dense stroma. After 3 weeks, pseudostratiﬁcation was no
longer observed and the epithelial cells were cuboidal. After 4
weeks (Fig. 2A–D), we observed dilated glands with pseudostratiﬁed
nuclei and a dense stroma.
In the LNG group, pseudostratiﬁcation of the nuclei and dense
stroma were observed after 1 week. As early as the second week,
the pseudostratiﬁed glandular epithelium was replaced by cuboidal
cells and the stromal density decreased. This morphology persisted
at week 3 and 4 (Fig. 2F–I). Heterogeneous decidualization was
observed in all mice in the LNG group after 4 weeks (Fig. 3). A
typical pseudodecidualized stroma associated with atrophic glands
was observed in eutopic endometrium in the LNG-IUS group
(Figs 2J and 3C).
Immunohistochemistry
All the quantitative results are presented in detail in Figs 4 and 5 for
the mouse model compared with eutopic endometrium. Eutopic pro-
liferative endometrium and endometrium treated for 1 month with
LNG served as comparisons for the E2 group and LNG group,
respectively (Fig. 6). We observed in mice in both glands and
stroma a signiﬁcant decrease in PRA and PRB immunoreactivity after
LNG administration, as it is also observed following insertion of a
LNG-IUS in women. ERa immunoreactivity in stromal cells was also
signiﬁcantly reduced by LNG treatment in both human and mouse
model. In glandular cells, the fall in ERa became signiﬁcant only at
weeks 2 and 4 in mouse model. Cell proliferation was signiﬁcantly
lower in glands in mouse and in women after LNG treatment than
in the E2 group and eutopic proliferative endometrium.
Figure 1 Haematoxylin–safran staining at 4 weeks after (A) endo-
metrial graft in SCID mouse treated with E2;( B) endometrial graft in
SCID mouse treated with E2þ LNG.
Scale bar ¼ 200 mm.
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The results are presented in detail in Fig. 7 for E2 compared with LNG
mice at 4 weeks. Considering both markers (SIF 100 or a-SMA), the
number of blood vessels did not differ between the two groups
(Fig. 7A), whereas the mean area was signiﬁcantly higher after LNG
treatment (Fig. 7B).
Discussion
Most studies analysing the effects of LNG on endometrium are
descriptive and have been performed on human endometrial biopsies.
In humans, intrauterine delivery of LNG induces profound morpho-
logical and functional effects on the endometrium, such as extensive
decidualization of stromal cells and atrophy of glandular epithelium
associated with altered vascular morphology (Maruo et al., 2001).
Down-regulation of ER and PR has also been observed in all cellular
components of the endometrium (Critchley et al., 1998b; Guttinger
and Critchley, 2007).
One study used a three-dimensional endometrial stromal and epi-
thelial cell co-culture to evaluate the effects of antiprogestin and
LNG on the blastocyst implantation (Lalitkumar et al., 2007; Meng
et al., 2008). This model is interesting to analyse the early events
linked to embryo implantation such as apposition, adhesion and
attachment of the embryo to the decidua, but presents limitations in
analysing the endometrial effect of LNG because of the absence of
vessels. Furthermore, we do not know whether this system keeps
endometrial characteristics for a period of up to 4 weeks as it was
used only for short-time culture (5 days to reach conﬂuence and 5
more days for blastocyst attachment).
Several animal models have been developed to study the pathophy-
siology of endometriotic disease and ectopic implantation of endo-
metrial cells using either endometrial tissue or endometriotic
biopsies (Grummer, 2006). However, few of these models have
been used to mimic the endometrial effects of progestin-only contra-
ceptives and to understand their endometrial side effects. Some
researchers analysed the effect of LNG on autologous mouse endo-
metrium in C57BL/6J mice (Girling et al., 2004; Morison et al.,
2007). However, since phylogenetic differences between species
limit our understanding of the diseases in human (in this case, side
effects associated with the use of local endometrial LNG), investigating
the effects of LNG on human endometrium implanted in animals
seems to be more promising than the study of the effects of LNG
on mouse endometrium.
Immunocompromized animals do not possess the ability to reject
foreign tissue and therefore appear ideal candidates for such studies.
According to the strain of mouse used to implant human endome-
trium subcutaneously, the graft can present various morphological
aspects. In nude mice, various degree of ﬁbrosis developed around
the endometrial graft. In contrast, human endometrial grafts in SCID
mice retained their normal histological features with no ﬁbrotic reac-
tion. The main difference between the two strains of mice is that nude
mice lack a thymus and cannot regenerate mature T lymphocytes,
while SCID mice lack both T and B lymphocytes. Other researchers
transplanted human endometrial tissue into RAG-2/g(c) mice
lacking lymphocytes T and B, as well as NK cells (Greenberg and
Slayden, 2004) or into NOD/SCID/gc
null mice, which are also defec-
tive in cytokine production (Matsuura-Sawada et al., 2005; Masuda
et al., 2007). In the study of Greenberg, the RAG-2/g(c) mice were
used to avoid graft rejection in long-term studies. These mice were
treated for  4 artiﬁcial cycles, each consisting of 14 days of E2 treat-
ment followed with 14 days E2þProgesterone. The non-obese dia-
betic (NOD/SCID/gc
null) mice are known to have a higher
acceptance rate for human tissue.
These last two models are interesting when grafts are maintained
for more than 4 weeks. In our study, we evaluated the effect of
LNG on the human endometrium grafted in mice for a maximum
period of 4 weeks to reproduce the effect of the ﬁrst month of
LNG-IUS use. Using SCID mice, we observed no rejection of the
Figure 2 Haematoxylin–eosin staining at 1, 2, 3 and 4 weeks after
endometrial graft in SCID mouse treated with E2 (A–D); endometrial
graft in SCID mouse treated with E2 þ LNG (F–I); (E) proliferative
eutopicendometrium;(J)eutopicendometriumwith1monthLNG-IUS.
S, stroma G, gland. Scale bar ¼ 100 mm.
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plants were recovered from 100% of mice, SCID mice were con-
sidered a suitable model to investigate the effects of LNG on the
endometrium.
In the present study, we used two groups of mice. The ﬁrst one was
treated with E2 to maintain the proliferative endometrium and to
demonstrate that the grafts present the same morphology as the
eutopic endometrium. The second group was treated with E2 and
LNG for comparison to eutopic endometrium of women treated
with LNG-IUS. We showed that human endometrial transplants
retained histological characteristics as well as reactivity to hormonal
manipulation similar to normal eutopic endometrium. At 4 weeks,
all grafts from mice treated with LNG presented similar morphology
to that observed in women exposed to LNG-IUS during 4 weeks,
i.e. features of extensive decidualization of stromal cells and atrophy
of glandular epithelium.
In the LNG group, cellular proliferation at 4 weeks was reduced in
glandular cells as previously described in women (Salmi et al., 1998;
Hurskainen et al., 2000; Maruo et al., 2001). Hurskainen et al.a n d
Maruo et al. described a fall in stromal cell proliferation by evaluating
endometrial proliferation 3–12 months after LNG-IUS insertion. We
evaluated cell proliferation within a shorter period of time: one
month after IUS insertion and after a maximum of 4 weeks LNG treat-
ment in mice. In the study of Salmi et al., more than half of the patients
retained some degree of stromal endometrial proliferation. In this study,
the cell proliferation analysis was performed as early as 1 month after
Figure 4 Immunostaining score (mean+SEM) in function of time in glands for (A) proliferation (Ki67), (B) oestrogen receptor a (ERa), (C) pro-
gesterone receptor A (PRA) and (D) progesterone receptor B (PRB).
Prolif, proliferative eutopic endometrium; LNG- IUS, 1 month LNG-IUS eutopic endometrium; E2, endometrial grafts in SCID mice treated with E2;
LNG, endometrial grafts in SCID mice treated with E2 þ LNG. NS, not signiﬁcant; *P , 0.05; **P , 0.01; ***P , 0.001.
Figure 3 Immunoperoxidase staining with monoclonal species-speciﬁc anti-human IGFBP1 antibody to visualize the decidualized cells.
Comparison between (A) endometrial graft in SCID mouse treated with E2 during 4 weeks; (B) endometrial graft in SCID mouse treated with
E2 þ LNG during 4 weeks; (C) eutopic endometrium with 1 month LNG-IUS. Insets show the appropriate isotype controls. Scale bar ¼ 100 mm.
Human endometrium treated with LNG in mice model 701IUS insertion up to 10 months after insertion of the device. The authors
did not specify how many patients had the IUS for 1 month. The per-
sistence of stromal proliferation in our model and in the
patients evaluated in our study as well as in the study of Salmi et al.
could be explained by difference in the design of these studies, with
the two latter studies being performed within a shorter time-lapse by
comparison with the studies of Hurskainen et al. and Maruo et al.
We also observed down-regulation of ERa,P R A and PRB in all cel-
lular components of the grafted endometrium. This down-regulation
conﬁrmed what we observed in eutopic endometrium treated with
LNG-IUS and was in good agreement with previously published data
(Critchley et al., 1998b).
Finally, at 4 weeks, we observed no signiﬁcant difference in the
number of blood vessel sections between the two experimental
groups, but a higher mean cross-sectional area of these vessels in the
LNG-treated animals. These data support the work of Jondet et al.
(2005) and McGavigan et al. (2003). Jondet et al. deducted from their
experiments and from additional observations of clinical data that
LNG has a dose-dependent action on the number and dilatation of
the blood vessels: the higher the plasmatic concentration, the lower
the number of blood vessel section and the higher their mean area.
One could consider that in our experimental design, the subcutaneous
administration of LNG close to the endometrial grafts led to a high local
dose of the drug and, consequently, to the observed effects on the vas-
culature. Finally, the morphological changes observed in the endometrial
vasculature induced by a treatment of 4 weeks with LNG were similar
to those published by Stephanie et al.( 2 0 0 7 ) .
In conclusion, the use of an animal model presents advantages in
comparison with descriptive studies in human: biopsy specimens
from each patient can be grafted into several mice, which ampliﬁes
the number of samples and allows studies with multiple purposes. In
the present experiment, we demonstrated that the graft of endome-
trium in SCID mice treated with E2 allows one to reproduce the
main characteristics of eutopic endometrium and to investigate the
local effects of LNG on human endometrium such as a decrease in
cell proliferation and in steroid hormone receptor scoring. This
model could therefore be used to further study pathophysiological
mechanisms underlying the onset of unscheduled BTB that impairs
the use of this hormonal therapeutic device and decreases the
quality of life of patients. The model represents also a useful tool to
develop a therapeutical strategy to overcome the problem of endo-
metrial bleeding before testing in humans.
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Figure 5 Immunostaining score (mean+SEM) in function of time in stromal cells for (A) proliferation (Ki67), (B) oestrogen receptor a (ERa), (C)
progesterone receptor A (PRA) and (D) progesterone receptor B (PRB).
Prolif, proliferative eutopic endometrium; LNG- IUS, 1 month LNG-IUS endometrium; E2, endometrial grafts in SCID mice treated with E2; LNG,
endometrial grafts in SCID mice treated with E2þLNG. NS, not signiﬁcant; *P , 0.05; **P , 0.01; ***P , 0.001.
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